Patriot Financial Group Insurance Agency, LLC Esperion Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$25.12 - $36.89 $3,140 - $4,611	-125 Closed	0 $0
Q4 2020 Jan 15, 2021	SELL	$24.2 - $35.76 $36,905 - $54,534	-1,525 Reduced 92.42%	125 $3,000
Q3 2020 Oct 21, 2020	BUY	$31.18 - $52.71 $35,857 - $60,616	1,150 Added 230.0%	1,650 $61,000
Q2 2020 Jul 10, 2020	BUY	$30.04 - $51.31 $1,502 - $2,565	50 Added 11.11%	500 $26,000
Q1 2020 Apr 15, 2020	BUY	$27.44 - $73.84 $4,116 - $11,076	150 Added 50.0%	450 $14,000
Q4 2018 Feb 04, 2019	BUY	$36.99 - $59.11 $11,097 - $17,733	300 New	300 $14,000

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account